Know the Latest Buprenorphine Option for Opioid Use Disorder

January 1

Another ER buprenorphine injection (Brixadi) for moderate to severe opioid use disorder is now available.

It’s still the partial agonist we know...but has differences from other buprenorphine products (Suboxone, Sublocade, etc).

Brixadi ($1,600/month) costs more than generic options, such as sublingual buprenorphine/naloxone tabs averaging $390/month, but Sublocade ($1,900/month) is similar in price.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote